Analyst picks & changes
Edward Hurwitz of Robertson Stephens initiated coverage of Agouron Pharmaceuticals Inc. with a "buy" in anticipation of mounting enthusiasm for HIV
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
